J&J reports 11.9 pct fall in quarterly profit
October 17, 2017 at 06:47 AM EDT
Oct 17 (Reuters) - Johnson & Johnson, which completed its $30 billion acquisition of Swiss biotech Actelion in June, reported a 11.9 percent fall in quarterly profit as costs rose.
